Order Article Reprints

Ragan IK, Hartson LM, Dutt TS, Obregon-Henao A, Maison RM, Gordy P, Fox A, Karger BR, Cross ST, Kapuscinski ML, et al. A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model. Vaccines. 2021; 9(4):340. https://doi.org/10.3390/vaccines9040340

Ragan, Izabela K, Lindsay M Hartson, Taru S Dutt, Andres Obregon-Henao, Rachel M Maison, Paul Gordy, Amy Fox, Burton R Karger, Shaun T Cross, Marylee L Kapuscinski, and et al. 2021. "A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model" Vaccines 9, no. 4: 340. https://doi.org/10.3390/vaccines9040340

Ragan, I. K., Hartson, L. M., Dutt, T. S., Obregon-Henao, A., Maison, R. M., Gordy, P., Fox, A., Karger, B. R., Cross, S. T., Kapuscinski, M. L., Cooper, S. K., Podell, B. K., Stenglein, M. D., Bowen, R. A., Henao-Tamayo, M., & Goodrich, R. P. (2021). A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model. Vaccines, 9(4), 340. https://doi.org/10.3390/vaccines9040340